

Please try another search
By Gina Lee
Investing.com – Gold was down on Wednesday morning in Asia, with increasing optimism over U.S. talks for the latest stimulus measures and a COVID-19 vaccine seeing a retreat from the safe-haven yellow metal.
Gold futures were down 0.32% at $1,813.15 by 12:25 AM ET (4:25 AM GMT), remaining over the $1,800 mark. Holdings of the SPDR Gold Trust (P:GLD) also fell 0.3% to 1,191.28 tons on Tuesday, from 1,194.78 tons on Monday.
Optimism grew after House of Representatives Speaker Nancy Pelosi and U.S. Treasury Secretary Steve Mnuchin held their first talks for the latest stimulus measures since the Nov. 3 presidential elections.
On the Republican side, Senate leader Mitch McConnell on Tuesday urged Congress to include a fresh wave of measures in a $1.4 trillion spending bill, aimed at heading off a government shutdown amid COVID-19. McConnell also teased a revised version of his own plan to fellow Republicans.
Emergency lending programs set up by the Federal Reserve during the pandemic could be revived quickly after they expire at year-end, senior New York Federal Reserve official Lorie Logan told a virtual discussion on Tuesday.
Although both Chicago Fed President Charles Evans and San Francisco Fed President Mary Daly said that they saw no immediate need for further monetary stimulus, Evans did call for more fiscal support.
Fed Chairman Jerome Powell was more cautious, issuing a warning that the U.S. economy remains in a damaged and uncertain state during his testimony at Tuesday’s Senate Banking Committee hearing. Powell will testify before Congress again later in the day. The Fed also meets for its policy meeting on Dec. 15 and 16.
Meanwhile, as the number of global COVID-19 cases continues to rise, a plan to inoculate Americans against COVID-19 as soon as mid-December was unveiled on Tuesday.
Developers could potentially meet that deadline, with BioNTech SE (F:22UAy) saying that shipment of the first doses of its candidate BNT162b2, co-developed with Pfizer Inc (NYSE:PFE), could happen “within hours” after approval.
Meanwhile, Moderna Inc (NASDAQ:MRNA) also announced plans earlier in the week to request clearance for its candidate mRNA-1273 in the U.S. and Europe. Both developers have applied for emergency European Union approval on Tuesday.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.